Table of Contents

Select this article
- J Ilonen,
- H Reijonen,
- E Herva,
- M Sjöroos,
- A Iitiä,
- T Lövgren,
- R Veijola,
- M Knip,
- and H K Akerblom
Rapid HLA-DQB1 genotyping for four alleles in the assessment of risk for IDDM in the Finnish population. The Childhood Diabetes in Finland (DiMe) Study Group.
Diabetes Care August 1996 19:795-800; doi:10.2337/diacare.19.8.795
- Abstract
Select this article
- A Green,
- A K Sjølie,
- and O Eshøj
Trends in the epidemiology of IDDM during 1970-2020 in Fyn County, Denmark.
Diabetes Care August 1996 19:801-806; doi:10.2337/diacare.19.8.801
- Abstract
Select this article
- J F Blanchard,
- S Ludwig,
- A Wajda,
- H Dean,
- K Anderson,
- O Kendall,
- and N Depew
Incidence and prevalence of diabetes in Manitoba, 1986-1991.
Diabetes Care August 1996 19:807-811; doi:10.2337/diacare.19.8.807
- Abstract
Select this article
- E Renard,
- S Bouteleau,
- D Jacques-Apostol,
- D Lauton,
- F Gibert-Boulet,
- G Costalat,
- J Bringer,
- and C Jaffiol
Insulin underdelivery from implanted pumps using peritoneal route. Determinant role of insulin pump compatibility.
Diabetes Care August 1996 19:812-817; doi:10.2337/diacare.19.8.812
- Abstract
Select this article
- L A Lavery,
- S A Vela,
- D C Lavery,
- and T L Quebedeaux
Reducing dynamic foot pressures in high-risk diabetic subjects with foot ulcerations. A comparison of treatments.
Diabetes Care August 1996 19:818-821; doi:10.2337/diacare.19.8.818
- Abstract
Select this article
- J M Ekoé,
- F Thomas,
- B Balkau,
- E Eschwege,
- and H Delisle
Effect of maternal diabetes on the pattern of selected insulin resistance syndrome parameters in normal glucose tolerant subjects of two Algonquin Indian communities in Quebec.
Diabetes Care August 1996 19:822-826; doi:10.2337/diacare.19.8.822
- Abstract
Select this article
- B E Klein,
- R Klein,
- S E Moss,
- and K J Cruickshanks
Parental history of diabetes in a population-based study.
Diabetes Care August 1996 19:827-830; doi:10.2337/diacare.19.8.827
- Abstract
Select this article
- L Tappy,
- E Gügolz,
- and P Würsch
Effects of breakfast cereals containing various amounts of beta-glucan fibers on plasma glucose and insulin responses in NIDDM subjects.
Diabetes Care August 1996 19:831-834; doi:10.2337/diacare.19.8.831
- Abstract
Select this article
- R E Glasgow,
- D J Toobert,
- and S E Hampson
Effects of a brief office-based intervention to facilitate diabetes dietary self-management.
Diabetes Care August 1996 19:835-842; doi:10.2337/diacare.19.8.835
- Abstract
Select this article
- M K Gutniak,
- H Larsson,
- S J Heiber,
- O T Juneskans,
- J J Holst,
- and B Ahrén
Potential therapeutic levels of glucagon-like peptide I achieved in humans by a buccal tablet.
Diabetes Care August 1996 19:843-848; doi:10.2337/diacare.19.8.843
- Abstract
Select this article
- R B Goldberg,
- S M Holvey,
- and J Schneider
A dose-response study of glimepiride in patients with NIDDM who have previously received sulfonylurea agents. The Glimepiride Protocol #201 Study Group.
Diabetes Care August 1996 19:849-856; doi:10.2337/diacare.19.8.849
- Abstract
Select this article
- M K Gutniak,
- L Juntti-Berggren,
- P M Hellström,
- A Guenifi,
- J J Holst,
- and S Efendic
Glucagon-like peptide I enhances the insulinotropic effect of glibenclamide in NIDDM patients and in the perfused rat pancreas.
Diabetes Care August 1996 19:857-863; doi:10.2337/diacare.19.8.857
- Abstract
Select this article
- L J Raffel,
- D C Robbins,
- J M Norris,
- E Boerwinkle,
- R A DeFronzo,
- S C Elbein,
- W Fujimoto,
- C L Hanis,
- S E Kahn,
- M A Permutt,
- K C Chiu,
- J Cruz,
- D A Ehrmann,
- R P Robertson,
- J I Rotter,
- and J Buse
The GENNID Study. A resource for mapping the genes that cause NIDDM.
Diabetes Care August 1996 19:864-872; doi:10.2337/diacare.19.8.864
- Abstract
Select this article
- B Haglund,
- K Ryckenberg,
- O Selinus,
- and G Dahlquist
Evidence of a relationship between childhood-onset type I diabetes and low groundwater concentration of zinc.
Diabetes Care August 1996 19:873-875; doi:10.2337/diacare.19.8.873
- Abstract
Select this article
- C J Thompson,
- J F Cummings,
- J Chalmers,
- C Gould,
- and R W Newton
How have patients reacted to the implications of the DCCT?
Diabetes Care August 1996 19:876-879; doi:10.2337/diacare.19.8.876
- Abstract
Select this article
- B B Yeap,
- A Russo,
- R J Fraser,
- G A Wittert,
- and M Horowitz
Hyperglycemia affects cardiovascular autonomic nerve function in normal subjects.
Diabetes Care August 1996 19:880-882; doi:10.2337/diacare.19.8.880
- Abstract
Select this article
- A D Mooradian,
- S G Albert,
- M Bernbaum,
- and S Plummer
The effect of glipizide gastrointestinal therapeutic system on islet cell hormonal responses to a test meal in NIDDM.
Diabetes Care August 1996 19:883-884; doi:10.2337/diacare.19.8.883
- Abstract
- R Stolarczyk,
- I Laufer,
- and L Poretsky
Absence of acanthosis nigricans in a patient with the type B syndrome of insulin resistance and preexisting diabetes.
Diabetes Care August 1996 19:885-886
Select this article
- T Shimonagata,
- S Nanto,
- M Hori,
- T Ohara,
- Y Kim,
- Y Takano,
- K Sakamoto,
- K Kamado,
- S Kubori,
- H Kusuoka,
- and T Nishimura
A case of hypertensive-diabetic cardiomyopathy demonstrating left ventricular wall motion abnormality.
Diabetes Care August 1996 19:887-891; doi:10.2337/diacare.19.8.887
- Abstract
- R C Turner and
- J C Levy
Notes on the GENNID Study.
Diabetes Care August 1996 19:892-895
- J A Colwell
Should we use intensive insulin therapy after oral agent failure in type II diabetes?
Diabetes Care August 1996 19:896-898
- D Lorber and
- E Krim
Beta-sympathomimetic therapy of premature labor.
Diabetes Care August 1996 19:899
- A L Peters and
- M B Davidson
Addition of hydrolyzed guar to enteral feeding products in type I diabetic patients.
Diabetes Care August 1996 19:899-900
- I Briceño,
- L A Barriocanal,
- S S Papiha,
- L A Ashworth,
- A Gómez,
- J E Bernal,
- K G Alberti,
- and M Walker
Lack of diabetes in rural Colombian Amerindians.
Diabetes Care August 1996 19:900-901
- O Kordonouri,
- T Danne,
- and B Weber
Do GAD antibodies at IDDM onset predict the clinical course of diabetes in children?
Diabetes Care August 1996 19:901-902
- F A Weisse
Physicians and rehabilitation for patients with vision loss.
Diabetes Care August 1996 19:902-903
- F R Velazquez and
- D Bartholomew
Effect of small sample volume on five glucose monitoring systems.
Diabetes Care August 1996 19:903-904
- G Bax,
- C Fagherazzi,
- F Piarulli,
- A Nicolucci,
- and D Fedele
Reproducibility of Michigan Neuropathy Screening Instrument (MNSI). A comparison with tests using the vibratory and thermal perception thresholds.
Diabetes Care August 1996 19:904-905
- Z T Bloomgarden
Conference report: approaches to the treatment of type II diabetes and developments in glucose monitoring and insulin administration.
Diabetes Care August 1996 19:906-909

Rapid HLA-DQB1 genotyping for four alleles in the assessment of risk for IDDM in the Finnish population. The Childhood Diabetes in Finland (DiMe) Study Group.

Trends in the epidemiology of IDDM during 1970-2020 in Fyn County, Denmark.

Incidence and prevalence of diabetes in Manitoba, 1986-1991.

Insulin underdelivery from implanted pumps using peritoneal route. Determinant role of insulin pump compatibility.

Reducing dynamic foot pressures in high-risk diabetic subjects with foot ulcerations. A comparison of treatments.

Effect of maternal diabetes on the pattern of selected insulin resistance syndrome parameters in normal glucose tolerant subjects of two Algonquin Indian communities in Quebec.

Parental history of diabetes in a population-based study.

Effects of breakfast cereals containing various amounts of beta-glucan fibers on plasma glucose and insulin responses in NIDDM subjects.

Effects of a brief office-based intervention to facilitate diabetes dietary self-management.

Potential therapeutic levels of glucagon-like peptide I achieved in humans by a buccal tablet.

A dose-response study of glimepiride in patients with NIDDM who have previously received sulfonylurea agents. The Glimepiride Protocol #201 Study Group.

Glucagon-like peptide I enhances the insulinotropic effect of glibenclamide in NIDDM patients and in the perfused rat pancreas.

The GENNID Study. A resource for mapping the genes that cause NIDDM.

Evidence of a relationship between childhood-onset type I diabetes and low groundwater concentration of zinc.

How have patients reacted to the implications of the DCCT?

Hyperglycemia affects cardiovascular autonomic nerve function in normal subjects.

The effect of glipizide gastrointestinal therapeutic system on islet cell hormonal responses to a test meal in NIDDM.

Absence of acanthosis nigricans in a patient with the type B syndrome of insulin resistance and preexisting diabetes.

A case of hypertensive-diabetic cardiomyopathy demonstrating left ventricular wall motion abnormality.

Notes on the GENNID Study.

Should we use intensive insulin therapy after oral agent failure in type II diabetes?

Beta-sympathomimetic therapy of premature labor.

Addition of hydrolyzed guar to enteral feeding products in type I diabetic patients.

Lack of diabetes in rural Colombian Amerindians.

Do GAD antibodies at IDDM onset predict the clinical course of diabetes in children?

Physicians and rehabilitation for patients with vision loss.

Effect of small sample volume on five glucose monitoring systems.

Reproducibility of Michigan Neuropathy Screening Instrument (MNSI). A comparison with tests using the vibratory and thermal perception thresholds.

Conference report: approaches to the treatment of type II diabetes and developments in glucose monitoring and insulin administration.

This Issue

Current Issue

From the Cover